… to assess left ventricular (LV) remodeling and … ventricular remodeling, as determinants of
HF. Therefore, this review focuses on the pathological mechanisms underlying LV remodeling …

… In the continuous presence of this causative factor, such remodeling becomes an irreversible
process leading to HF.Te pathological ventricular remodeling is characterized by 3 main …

Mechanisms of right ventricular (RV) dysfunction in heart failure (HF) are poorly understood.
RV response to volume overload (VO), a common contributing factor to HF, is rarely studied. …

… heart failure (HF) and type 2 diabetes mellitus (T2DM) on left ventricular (LV) remodeling …
In our cohort, dapagliflozin had no effect on LVESV or any other parameter of LV remodeling. …

… by myocardial ischemia leads to left ventricular remodeling; this process involves changes
in cardiac geometry, dimension and function and eventually progression to heart failure (HF). …

… model of heart failure, empagliflozin ameliorates adverse left ventricular remodeling and …
inhibitors should be studied in both diabetic and nondiabetic patients with heart failure. …

… remodeling causes LV diastolic and systolic dysfunction, which may consequently lead to
clinical complications such as heart failure, atrial fibrillation, ischemic heart … LV remodeling and …

… activation, microvascular thrombosis and transforming growth factor (TGF) β1 signaling
and a late phase of myocardial fibrosis, ventricular remodeling and ultimately heart failure …

… Ventricular remodeling is a pivotal process associated with progression of heart failure with
… sacubitril/valsartan relative to changes in ventricular remodeling indices, with a broad range …

… To antagonize ERα, we tested a novel ERβ agonist (OSU-ERb-012) to inhibit T cells and
blunt left ventricular remodeling. Proliferation assays showed that OSU-ERb-012 dose-…